YOLFTbeta
Guangxi Liuzhou Pharm Co Ltd

Guangxi Liuzhou Pharm Co Ltd

603368 · SHG · Healthcare / Medical Distribution

16.28CNY-0.16 (-0.97%)

Price History

Full chart

Market Stats

Previous Close16.44
Open16.40
Day Range16.23 – 16.61
52-Week Range14.34 – 19.64
Volume6.25M
Market Cap6.03B
P/E (TTM)9.26
Forward P/E0.00
EPS1.64
Dividend Yield4.48%
Beta0.37
50-Day Avg15.69
200-Day Avg16.68

About

Guangxi LiuYao Group Co., Ltd engages in the manufacturing, wholesale, and retail of pharmaceutical products in China. It offers various types of medicines, medical devices, consumables, diagnostic reagents, other innovative drugs, and self-produced products through online pharmacies and terminal physical pharmacies. The company also offers health consultations and engages in food manufacturing. Guangxi LiuYao Group Co., Ltd was founded in 1981 and is based in Liuzhou, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Distribution
  • CEOMr. Chaoyang Zhu
  • Employees5.63K
  • HeadquartersNo. 68, Guantang Avenue, Liuzhou, China, 545000, China
  • Websitehttps://web.lzyy.cn

Leadership

  • Mr. Chaoyang ZhuChairman & CEO · b. 1966
  • Mr. Xiangxing ZengVP, CFO & Accounting Supervisor · b. 1982
  • Ms. Chunxue TangVP & Employee Representative Director · b. 1979
  • Mr. Xianhua ZhuVP & Director · b. 1982
  • Mr. Yang XuBoard Secretary · b. 1990
  • Mr. Xian Rong TangVice President · b. 1972
  • Mr. Jun Xiong XiaoVice President · b. 1974
  • Mr. Zhen LiangVice President · b. 1981

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.73B3.56B4.55B5.66B6.51B7.56B9.45B11.71B14.86B15.67B17.13B19.05B20.81B21.18B20.93B
Growth (%)-+30.42%+27.82%+24.35%+15.07%+16.16%+24.97%+24.00%+26.82%+5.46%+9.36%+11.19%+9.23%+1.78%-1.21%
Cost of Revenue2.50B3.26B4.15B5.16B5.95B6.86B8.55B10.48B13.08B13.75B15.22B16.90B18.37B18.80B18.61B
Gross Profit226.78M300.79M394.44M495.32M559.17M701.98M893.66M1.24B1.77B1.91B1.92B2.15B2.44B2.38B2.31B
Gross Margin8.31%8.45%8.67%8.76%8.59%9.29%9.46%10.58%11.94%12.21%11.19%11.30%11.73%11.25%11.05%
Operating Expense104.15M139.35M208.49M275.11M295.29M299.58M386.99M573.08M876.82M1.01B1.16B1.26B1.40B1.38B1.16B
Operating Income122.64M161.44M185.96M220.21M263.88M402.40M506.67M666.30M896.59M904.63M753.09M890.06M1.04B1.00B1.15B
Operating Margin4.50%4.54%4.09%3.89%4.05%5.32%5.36%5.69%6.03%5.77%4.40%4.67%5.01%4.74%5.49%
EBITDA126.20M164.95M226.96M276.86M307.19M401.22M536.48M739.40M1.07B1.14B1.02B1.20B1.38B1.33B1.29B
EBITDA Margin4.63%4.64%4.99%4.90%4.72%5.31%5.68%6.31%7.17%7.27%5.94%6.28%6.62%6.27%6.17%
Net Income83.53M104.35M149.42M169.80M208.38M321.01M401.38M528.19M685.43M711.71M563.82M701.52M849.59M854.87M709.46M
Net Income Margin3.06%2.93%3.29%3.00%3.20%4.25%4.25%4.51%4.61%4.54%3.29%3.68%4.08%4.04%3.39%
R&D--------2.78M8.74M18.61M25.79M36.64M42.71M38.47M
R&D as % of Total Revenue--------0.02%0.06%0.11%0.14%0.18%0.20%0.18%
Interest Expense14.25M26.06M39.51M53.76M36.54M9.07M22.18M57.81M121.96M189.76M192.70M241.00M249.57M237.76M221.13M
Interest Expense % of Total Revenue0.52%0.73%0.87%0.95%0.56%0.12%0.23%0.49%0.82%1.21%1.12%1.26%1.20%1.12%1.06%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.57B2.03B2.70B3.74B4.30B6.28B7.55B9.77B11.96B14.81B15.87B18.61B20.16B21.27B21.34B
Total Liabilities1.30B1.65B2.20B2.56B2.94B3.04B3.99B5.73B7.30B9.36B10.07B12.24B13.10B13.33B13.20B
Total Equity274.23M378.59M501.00M1.16B1.33B3.19B3.49B3.85B4.37B5.10B5.46B5.97B6.62B7.62B7.83B
Cash398.56M593.47M668.14M932.28M723.91M1.72B1.07B1.24B1.92B3.50B3.42B3.85B3.15B3.68B3.79B
Total Debt263.50M422.14M595.41M634.63M681.12M263.00M623.67M1.75B2.25B3.63B3.92B4.34B4.42B4.08B-
Net Debt-135.06M-171.33M-72.73M-297.65M-42.79M-1.45B-450.07M513.02M337.38M137.17M507.24M489.44M1.16B393.10M-

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow133.38M60.51M22.33M-132.42M-107.25M108.39M-332.59M22.30M412.91M664.69M332.88M506.43M594.41M838.51M1.08B
Investing Cash Flow-36.78M-12.80M-74.30M-120.87M-130.85M-178.99M-555.21M-648.63M-63.20M-244.42M-292.98M-383.43M-202.01M-142.34M-
Financing Cash Flow112.44M133.46M134.34M477.18M77.86M1.10B244.19M700.40M381.93M1.16B-240.74M-731.12M-397.08M53.44M-
Capital Expenditure36.78M12.81M74.31M121.93M135.01M127.33M189.76M271.61M249.54M261.81M264.04M183.28M172.94M147.87M184.49M
Free Cash Flow96.60M47.70M-51.98M-254.35M-242.26M-18.95M-522.35M-249.31M163.38M402.87M68.84M323.15M421.46M690.64M893.17M
Dividends Paid45.60M24.11M55.48M94.01M71.87M96.97M119.23M230.20M158.71M314.47M217.46M173.91M353.76M412.35M449.52M
FCF to OCF72.42%78.83%-232.78%192.08%225.89%-17.48%157.05%-1117.98%39.57%60.61%20.68%63.81%70.90%82.36%82.88%
Dividend Paid to FCF47.21%50.55%-106.73%-36.96%-29.67%-511.79%-22.83%-92.33%97.15%78.06%315.88%53.82%83.94%59.71%50.33%

Earnings

Report DateApr 28, 2015Sep 2, 2015Oct 28, 2015Mar 29, 2016Apr 27, 2016Aug 17, 2016Oct 26, 2016Mar 21, 2017Apr 17, 2017Jul 20, 2017Oct 25, 2017Feb 7, 2018Apr 24, 2018Jul 24, 2018Oct 21, 2018Feb 19, 2019Apr 21, 2019Jul 18, 2019Oct 29, 2019Apr 29, 2020Jul 31, 2020Oct 27, 2020Feb 24, 2021Apr 28, 2021Aug 18, 2021Oct 26, 2021Mar 30, 2022Apr 27, 2022Aug 17, 2022Oct 16, 2022Feb 27, 2023Apr 19, 2023
EPS Estimate-------------0.490.360.36-0.450.470.47--0.64----0.64----
EPS Actual0.140.210.200.180.200.230.230.250.230.300.270.310.310.390.380.380.440.540.530.510.580.590.280.570.340.470.180.280.410.570.350.72
Surprise--------------20.41%5.56%5.56%-20.00%12.77%8.51%---56.25%-----56.25%----
TimingPre-market-Pre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hours

Key Statistics & Ratios

Market Cap6.03B
Enterprise Value6.98B
Trailing P/E9.26
Forward P/E0.00
Price / Sales0.29
Price / Book0.77
EPS1.64
Book Value20.32
Revenue (TTM)21.15B
Gross Profit (TTM)2.25B
EBITDA1.11B
Profit Margin3.07%
Operating Margin4.02%
Return on Equity8.03%
Return on Assets3.02%
Shares Outstanding397.21M
Shares Float269.88M
Beta0.37
Dividend Yield4.48%
Dividend Rate0.68
Payout Ratio41.46%

Dividends

20231×
0.51Jun 8, 2023
20221×
0.48Jun 17, 2022
20211×
0.60Jun 10, 2021
20201×
0.68Jun 24, 2020
20191×
0.44May 28, 2019
20181×
0.47May 9, 2018
20171×
0.36May 10, 2017
20161×
0.24May 10, 2016
20151×
0.12May 8, 2015

Stock Splits

  • Jun 24, 20207:5
  • May 9, 20187:5
  • May 10, 201793773:72133